| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.63B | 3.15B | 2.37B | 2.17B | 1.20B | 2.05B |
| Gross Profit | 1.86B | 2.38B | 1.71B | 1.64B | 741.00M | 1.68B |
| EBITDA | 2.05B | 2.19B | 1.59B | 1.54B | 655.00M | 1.60B |
| Net Income | 1.15B | 1.30B | 1.52B | 1.52B | 600.00M | 1.57B |
Balance Sheet | ||||||
| Total Assets | 30.68B | 31.23B | 28.25B | 23.80B | 22.40B | 20.84B |
| Cash, Cash Equivalents and Short-Term Investments | 505.00M | 924.00M | 635.00M | 535.00M | 303.00M | 372.00M |
| Total Debt | 0.00 | 15.99B | 13.76B | 11.95B | 12.38B | 11.16B |
| Total Liabilities | 16.61B | 16.92B | 14.90B | 12.60B | 12.84B | 11.97B |
| Stockholders Equity | 14.06B | 14.32B | 13.36B | 11.20B | 9.55B | 8.87B |
Cash Flow | ||||||
| Free Cash Flow | 1.14B | 1.14B | 1.28B | 1.00B | 746.00M | 935.00M |
| Operating Cash Flow | 1.14B | 1.14B | 1.28B | 1.00B | 746.00M | 935.00M |
| Investing Cash Flow | -2.31B | -2.86B | -3.41B | -489.00M | -2.10B | -3.39B |
| Financing Cash Flow | 1.15B | 1.78B | 2.42B | -284.00M | 1.21B | 2.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | $13.36B | 8.13 | 9.22% | 9.64% | 7.19% | -24.22% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | $4.86B | 10.94 | 16.94% | 7.17% | 5.64% | -5.45% | |
63 Neutral | $3.53B | 13.71 | 8.30% | 11.70% | 19.61% | -9.66% | |
62 Neutral | $2.84B | 9.36 | 15.88% | 10.00% | 6.44% | 16.72% | |
60 Neutral | $16.49B | 48.03 | 16.10% | 3.03% | 33.56% | 6716.41% | |
56 Neutral | $2.94B | -9.10 | 0.18% | 18.52% | -6.62% | -98.12% |